Moreover, Huang et al. found that the NUPR1 inhibitor ZZW-115 downregulates mitochondrial biogenesis regulator Mitochondrial Transcription Factor A (TFAM), thereby reducing the antioxidant capacity in pancreatic cancer cells [66]. The gene discussed is TFAM; the disease is pancreatic neoplasm.